Search Result "RIP-LCMV mouse"
History and Milestones of Mouse Models of Autoimmune Diseases
Journal: Current Pharmaceutical Design
Volume: 21 Issue: 1 Year: 2015 Page: 2308-2319
Author(s): Xinhua Yu, Qiaoniang Huang, Frank Petersen
Chemokines as Drug Targets in Type 1 Diabetes
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 7 Issue: 1 Year: 2007 Page: 7-12
Author(s): Urs Christen
The Role of Toll-Like Receptor Pathways in the Mechanism of Type 1 Diabetes
Journal: Current Molecular Medicine
Volume: 9 Issue: 1 Year: 2009 Page: 52-68
Author(s): Egil Lien, Danny Zipris
Viral Infection - A Cure for Type 1 Diabetes?
Journal: Current Medicinal Chemistry
Volume: 14 Issue: 1 Year: 2007 Page: 2048-2052
Author(s): Edith Hintermann, Urs Christen
An Update on Animal Models of Autoimmune Hepatitis: Are we There Yet?
Journal: Current Pharmaceutical Design
Volume: 21 Issue: 1 Year: 2015 Page: 2391-2400
Author(s): Urs Christen, Edith Hintermann
Peptide Immunotherapies in Type 1 Diabetes: Lessons from Animal Models
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 4 Year: 2011 Page: 577-586
Author(s): A. Fierabracci
Ribosome Inactivating Proteins (RIPs) from Momordica charantia for Anti Viral Therapy
Journal: Current Molecular Medicine
Volume: 9 Issue: 9 Year: 2009 Page: 1080-1094
Author(s): M. Puri, I. Kaur, R. K. Kanwar, R. C. Gupta, A. Chauhan, J. R. Kanwar
Antiviral Agents in the Prevention and Treatment of Virus-Induced Diabetes
Journal: Anti-Infective Agents in Medicinal Chemistry
Volume: 5 Issue: 3 Year: 2006 Page: 293-307
Author(s): A. S. Galabov, A. Angelova
Pancreatic Islets Under Attack: Cellular and Molecular Effectors
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 7 Year: 2007 Page: 749-760
Author(s): Michal Pearl-Yafe, Ayelet Kaminitz, Esma S. Yolcu, Isaac Yaniv, Jerry Stein, Nadir Askenasy
Regulation of T Cell Signaling and Function by Cbl-b
Journal: Current Immunology Reviews
Volume: 3 Issue: 4 Year: 2007 Page: 269-275
Author(s): Wallace Y. Langdon, Christine B.F. Thien